CCO Infectious Disease Podcast

Key Decisions in HIV Care: Treating HIV/HCV Coinfection

Episode Summary

Listen as Mark S. Sulkowski, MD, shares the latest data and recommendations for treating HIV and HCV in patients who are coinfected, including considerations for HCV treatment as prevention and the impact of HCV treatment on the HIV care cascade.

Episode Notes

In this episode, Mark S. Sulkowski, MD, explores recommendations and data on treating HIV and hepatitis C virus (HCV) in patients who are coinfected.

Listen as he gives his perspectives on:

• Prioritization of both HIV and HCV treatment
• Efficacy of HCV direct-acting antivirals in people with HIV
• American Association for the Study of Liver Diseases/Infectious Diseases Society of America recommendations for first-line HCV treatment in HIV/HCV coinfection
• International guidance on first-line antiretroviral therapy
• HIV/HCV drug–drug interactions
• The Swiss HCVree Trial of HCV treatment as prevention in men who have sex with men with HIV
• Dependence of HCV elimination on the HIV care continuum for people who are HIV/HCV coinfected

Presenter:

Mark S. Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Chief, Infectious Disease
Johns Hopkins Bayview Medical Center
Johns Hopkins University School of Medicine
Baltimore, Maryland  

Follow along with the slides at:
 https://bit.ly/3oUi29g

Link to full program:
https://bit.ly/3fOl0XX